Sprycel市场，按应用，按年龄组，按配销通路：按地区

预计 2023 年全球Sprycel市场规模为 22.2 亿美元，预计到 2030 年将达到 26.9 亿美元，预测期内复合年增长率为 2.8%。

图 1. Sprycel全球市场占有率(%)，依地区划分，2023 年

Sprycel是Dasatinib的品牌名称，达沙替尼是一种用于治疗某些类型癌症的药物。Dasatinib属于一组称为蛋白酪氨酸激酶抑制剂 (TKI) 的药物。Dasatinib透过抑制某些蛋白酪氨酸激酶（参与癌细胞生长和转移的酵素）的活性发挥作用。 Sprycel是标靶药物，主要用于治疗某些类型的白血病，特别是急性淋巴性白血病（ALL）（Ph+ALL）和慢性骨髓性白血病（CML），其特征是存在费城染色体。 Sprycel的常见副作用包括疲劳、头痛、噁心、腹泻和体液储存。有些患者可能会出现更严重的副作用，例如血球数量减少、肝损伤和出血。您的医疗保健提供者的密切监测对于管理和解决副作用非常重要。它适用于诊断患有 CML 的成人和 12 个月及以上的儿童。它也适用于患有特定亚型急性淋巴细胞白血病（称为费城染色体阳性或 Ph+ALL）的同一年龄层的成人和儿童。白血病是一种恶性，涉及骨髓内发育的未成熟白血球。正常情况下，一旦这些白血球成熟，它们就会进入血液中以抵抗感染疾病并维持人体的免疫系统。

市场动态：

目标适应症的增加、其功效和安全性、适应症的扩展和创新进步是预计在预测期内推动全球Sprycel市场成长的主要因素。癌症研究和治疗的进步，包括Sprycel等标靶治疗的开发，扩大了医疗保健提供者和患者的选择范围。这使得Sprycel越来越多地被采用作为治疗方法的一部分。

然而，激烈的竞争、专利到期、监管挑战、副作用、定价和报销预计将阻碍预测期内全球Sprycel市场的成长。

本研究的主要特点

• 本报告对全球Sprycel市场进行了详细分析，并介绍了以 2022 年为基准年的预测期（2023-2030）的市场规模和復合年增长率。
• 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
• 它根据以下参数（例如公司亮点、产品系列、主要亮点、财务表现和策略）对全球Sprycel市场的主要企业进行了介绍。
• 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
• 全球Sprycel市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于分析全球Sprycel市场的各种策略矩阵，将促进相关人员的决策。

目录：

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 目标适应症、疗效和安全性的普及以及适应症的扩大
  • 激烈的竞争、专利到期和监管挑战
  • 革命性的进步
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第四章全球Sprycel市场 – 冠状冠状病毒(COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章 全球Sprycel市场，依应用划分，2018-2030 年

• 慢性骨髓性白血病（CML）
• 费城染色体阳性急性淋巴性白血病 (Ph+ALL)

第六章 全球Sprycel市场，依年龄划分，2018-2030

• 成年患者
• 儿童患者

第 7 章 全球Sprycel市场（依配销通路），2018-2030

• 医院和诊所
• 零售药房
• 网路药房
• 专业药房

第 8 章 全球Sprycel市场（按地区）2018-2030 年

• 北美洲
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 义大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• ASEAN
• 澳洲
• 韩国
• 其他亚太地区
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中东
• GCC
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中部非洲
• 南非

第9章 竞争形势

• Bristol-Myers Squibb（BMS）

第10章

• 调查方法
• 关于出版商

The global Sprycel market size is estimated to be valued at US$ 2.22 billion in 2023 and is projected to reach US$ 2.69 billion by 2030, growing at a CAGR of 2.8% during the forecast period.

Figure 1. Global Sprycel Market Share (%), by Region, 2023

Sprycel is the brand name for dasatinib, a medication used in the treatment of certain types of cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). Dasatinib works by inhibiting the activity of specific tyrosine kinases, which are enzymes involved in the growth and spread of cancer cells. Sprycel is a targeted medication primarily employed in the treatment of certain types of leukemia, specifically acute lymphoblastic leukemia (ALL), characterized by the presence of the Philadelphia chromosome (Ph+ ALL), and chronic myeloid leukemia (CML). Common side effects of Sprycel may include fatigue, headache, nausea, diarrhea, and fluid retention. Some patients may also experience more serious side effects, such as low blood cell counts, liver problems, and bleeding. Close monitoring by healthcare providers is important to manage and address any adverse effects. It is administered to both adults and children aged 12 months and older who are diagnosed with CML. Additionally, it is prescribed for adults and children in the same age group who are afflicted with a specific subtype of acute lymphoblastic leukemia known as Philadelphia chromosome-positive or Ph+ ALL. Leukemia is a malignancy involving immature white blood cells that develop within the bone marrow. In the normal course of events, as these white blood cells mature, they enter the bloodstream to combat infections and maintain the body's immune system.

Market Dynamics:

The increasing prevalence of targeted indications, their efficacy and safety profile, expanded indications, and innovative advancements are major factors expected to drive growth of the global sprycel market during the forecast period. Advancements in cancer research and treatment, including the development of targeted therapies like Sprycel, have expanded the options available to healthcare providers and patients. This has led to increased adoption of Sprycel as part of the treatment regimen.

However, strong competition, patent expiration, regulatory challenges, adverse effects, and pricing and reimbursement are expected to hamper the growth of the global Sprycel market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global Sprycel market, and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Sprycel market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bristol-Myers Squibb (BMS)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Sprycel market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Sprycel market

Detailed Segmentation:

• By Application:
  • Chronic myeloid leukemia (CML)
  • Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
• By Age Group:
  • Adult Patients
  • Pediatric Patients
• By Distribution Channel:
  • Hospitals and Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Specialty Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• By Company Profiles:
  • Bristol-Myers Squibb (BMS)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Global Sprycel, By Application
  • Market Global Sprycel, By Age Group
  • Market Global Sprycel, By Distribution Channel
  • Market Global Sprycel, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of targeted indications, efficacy and safety profile, expanded indications
  • Strong competition, patent expiration, regulatory challenges
  • Innovative advancements
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Sprycel Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Sprycel Market, By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Chronic myeloid leukemia (CML)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Sprycel Market, By Age Group, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Adult Patients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Pediatric Patients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Sprycel Market, By Distribution Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Specialty Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Sprycel Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Bristol-Myers Squibb (BMS)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us